세계의 동맥절개용 폐쇄 디바이스 시장 : 제품 유형, 수술 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Arteriotomy Closure Devices Market was valued at USD 1.26 billion in 2023, expected to reach USD 1.34 billion in 2024, and is projected to grow at a CAGR of 6.50%, to USD 1.96 billion by 2030.

Arteriotomy closure devices are critical innovations designed to seal arterial puncture sites post-procedures such as catheterization, thereby enhancing patient recovery and reducing complications. The necessity for these devices arises from their ability to minimize procedural time, reduce bleeding risks, and accelerate patient ambulation, ultimately improving overall medical efficiencies. These devices are primarily applicable in cardiovascular interventions and peripheral angiographies, with end-users ranging from hospitals, surgical centers, to specialized cardiac care facilities. The market is experiencing growth due to an increasing number of minimally invasive surgeries, a rise in cardiovascular diseases, and demand for shorter hospital stays. Notably, aging populations and unhealthy lifestyle trends have escalated the number of interventions requiring closure devices. Key growth factors include advancements in device technologies, such as bioresorbable and active sealing products, and the expansion of healthcare infrastructures in emerging markets. However, potential opportunities lie in developing cost-effective devices and expanding to untapped rural regions with rising incidences of cardiovascular patients needing care. Conversely, limitations include high costs of devices and procedures, stringent regulatory frameworks, and possible device-related complications, which could deter market expansion. The market is presently competitive, with companies investing in research to innovate features like quicker deployment and improved patient outcomes, positioning product differentiation as a driver of market share. Challenges such as adoption resistance due to traditional methods and lack of skilled healthcare professionals in certain regions add layers of complexity. Innovation could be directed towards creating more efficient closure techniques, integrating AI and robotic assistance for precision, which could reduce procedural errors. The market is poised for further growth, driven by healthcare reforms and patient-centric care models, presenting a dynamic landscape ripe for technological breakthroughs and strategic partnerships.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arteriotomy Closure Devices Market

The Arteriotomy Closure Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiovascular diseases requiring arteriotomy procedures and advanced closure techniques
  • Growing geriatric population leading to higher incidences of artery-related complications requiring closure devices
  • Rising preference for minimally invasive procedures in vascular surgeries driving demand for effective closure solutions
• Market Restraints
  • Limited awareness and training among healthcare professionals about advanced arteriotomy closure techniques
  • Potential complications and risks associated with the use of arteriotomy closure devices
• Market Opportunities
  • Continued clinical trials and studies proving the efficacy and safety of new devices
  • Collaborations and partnerships among key players expanding market reach and innovation
• Market Challenges
  • Disruptions in the global supply chain, such as those caused by geopolitical tensions or pandemics

Porter's Five Forces: A Strategic Tool for Navigating the Arteriotomy Closure Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arteriotomy Closure Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arteriotomy Closure Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arteriotomy Closure Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arteriotomy Closure Devices Market

A detailed market share analysis in the Arteriotomy Closure Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arteriotomy Closure Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arteriotomy Closure Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arteriotomy Closure Devices Market

A strategic analysis of the Arteriotomy Closure Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arteriotomy Closure Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aesculap, Inc., Arstasis, Inc., Artivion, Inc., Boston Scientific Corporation, Cardinal Health, Inc., CytoSorbents Corporation, Fumedica AG, Humacyte Global Inc., iVascular, S.L.U, IVT Medical Ltd., KOAG LLC, Medtronic plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Mitralign Inc., Teleflex Incorporated, Terumo Medical Corporation, TOTAL Vein Solutions, LLC, Transluminal Technologies Inc., Tricol Biomedical Inc., and Vasorum Ltd..

Market Segmentation & Coverage

This research report categorizes the Arteriotomy Closure Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Active Closure Devices and Passive Closure Devices. The Active Closure Devices is further studied across Clip-Based Devices, Collagen-Based Devices, Plug-Based Devices, and Suture-Based Devices. The Passive Closure Devices is further studied across Compression Assist Devices and Manual Compression Devices.
• Based on Procedure Type, market is studied across Coronary Angiography, Percutaneous Coronary Intervention, Peripheral Angiography, and Peripheral Intervention.
• Based on Application, market is studied across Interventional Cardiology, Neurovascular Interventions, and Peripheral Vascular Interventions.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, Hospitals, and Specialty Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular diseases requiring arteriotomy procedures and advanced closure techniques
    • 5.1.1.2. Growing geriatric population leading to higher incidences of artery-related complications requiring closure devices
    • 5.1.1.3. Rising preference for minimally invasive procedures in vascular surgeries driving demand for effective closure solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and training among healthcare professionals about advanced arteriotomy closure techniques
    • 5.1.2.2. Potential complications and risks associated with the use of arteriotomy closure devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Continued clinical trials and studies proving the efficacy and safety of new devices
    • 5.1.3.2. Collaborations and partnerships among key players expanding market reach and innovation
  • 5.1.4. Challenges
    • 5.1.4.1. Disruptions in the global supply chain, such as those caused by geopolitical tensions or pandemics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Proliferating demand for active closure devices to close vessels with precision and efficiency
  • 5.2.2. Procedure Type : Increased adoption of arteriotomy closure devices in various procedure types for quick patient recovery

• 5.2.3. Application: Arteriotomy closure devices driving advancements in interventional cardiology, neurovascular, and peripheral vascular markets with innovative and patient-centric solutions
• 5.2.4. End-User: Innovative arteriotomy closure devices driving efficiency and safety across ASCs, clinics, hospitals and specialty centers through advanced technologies and strategic collaborations
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Arteriotomy Closure Devices Market, by Product

• 6.1. Introduction
• 6.2. Active Closure Devices
  • 6.2.1. Clip-Based Devices
  • 6.2.2. Collagen-Based Devices
  • 6.2.3. Plug-Based Devices
  • 6.2.4. Suture-Based Devices
• 6.3. Passive Closure Devices
  • 6.3.1. Compression Assist Devices
  • 6.3.2. Manual Compression Devices

7. Arteriotomy Closure Devices Market, by Procedure Type

• 7.1. Introduction
• 7.2. Coronary Angiography
• 7.3. Percutaneous Coronary Intervention
• 7.4. Peripheral Angiography
• 7.5. Peripheral Intervention

8. Arteriotomy Closure Devices Market, by Application

• 8.1. Introduction
• 8.2. Interventional Cardiology
• 8.3. Neurovascular Interventions
• 8.4. Peripheral Vascular Interventions

9. Arteriotomy Closure Devices Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Clinics
• 9.4. Hospitals
• 9.5. Specialty Centers

10. Americas Arteriotomy Closure Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Arteriotomy Closure Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Arteriotomy Closure Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Cordis partners with Premier, Inc. to provide MYNX CONTROL VENOUS Vascular Closure Device for enhanced patient outcomes and operational efficiency
  • 13.3.2. Haemonetics announces limited release of VASCADE MVP XL, targeting larger sheaths and rapid hemostasis for expanded market presence
  • 13.3.3. Terumo Medical's USD 30 million expansion in Puerto Rico to meet global demand for Angio-Seal vascular closure device
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aesculap, Inc.
• 3. Arstasis, Inc.
• 4. Artivion, Inc.
• 5. Boston Scientific Corporation
• 6. Cardinal Health, Inc.
• 7. CytoSorbents Corporation
• 8. Fumedica AG
• 9. Humacyte Global Inc.
• 10. iVascular, S.L.U
• 11. IVT Medical Ltd.
• 12. KOAG LLC
• 13. Medtronic plc
• 14. Meril Life Sciences Pvt. Ltd.
• 15. Merit Medical Systems, Inc.
• 16. Mitralign Inc.
• 17. Teleflex Incorporated
• 18. Terumo Medical Corporation
• 19. TOTAL Vein Solutions, LLC
• 20. Transluminal Technologies Inc.
• 21. Tricol Biomedical Inc.
• 22. Vasorum Ltd.